TP53BP2: Roles in suppressing tumorigenesis and therapeutic opportunities

Yunfei Huo1, Ke Cao1, Buxin Kou1

  • 1Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.

Genes & Diseases
|July 26, 2023
PubMed

Insights

Apoptosis stimulating protein 2 of p53 (ASPP2) is crucial in tumor development and impacts patient survival. Targeting ASPP2 offers potential new strategies for treating malignant tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • Malignant tumors pose a significant global health challenge.
  • Tumor suppressor p53-binding protein 2 (TP53BP2), also known as apoptosis stimulating protein 2 of p53 (ASPP2), is vital in tumorigenesis.
  • TP53BP2 expression correlates with patient prognosis and survival rates in malignant tumors.

Purpose of the Study:

  • To review the multifaceted role of TP53BP2 in tumor development.
  • To elucidate the signaling pathways regulated by TP53BP2.
  • To highlight TP53BP2 as a potential therapeutic target for cancer treatment.

Main Methods:

  • Literature review of studies on TP53BP2 function in tumorigenesis.
  • Analysis of TP53BP2 interactions with key proteins (e.g., p53, NF-κB p65, YAP).
  • Examination of TP53BP2's regulation of cellular processes (proliferation, apoptosis, migration, EMT, drug resistance) via signaling pathways.

Main Results:

  • TP53BP2 interacts with numerous proteins to modulate cellular functions.
  • TP53BP2 influences critical cancer hallmarks including proliferation, apoptosis, migration, EMT, and drug resistance.
  • TP53BP2 regulates downstream pathways such as NF-κB, RAS/MAPK, and PI3K/AKT.

Conclusions:

  • TP53BP2 plays a critical role in both p53-dependent and independent pathways during tumorigenesis.
  • Understanding TP53BP2's regulatory network provides insights into cancer progression.
  • TP53BP2 represents a promising therapeutic target for developing novel anti-cancer strategies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K